Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac Surgery Using the Heart-lung-machine

NCT07661940 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

AKI - Acute Kidney Injury

Interventions

DRUG: SP16-3M
DRUG: Placebo

Sponsor

University of Erlangen-Nürnberg Medical School

Collaborators

[object Object]